Anchen Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Anchen Pharmaceuticals's estimated annual revenue is currently $8M per year.(i)
  • Anchen Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Anchen Pharmaceuticals has 40 Employees.(i)
  • Anchen Pharmaceuticals grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Anchen Pharmaceuticals?

Anchen Pharmaceuticals, Inc., headquartered in Irvine, California, is a specialty pharmaceutical company focused on the development and commercialization of extended release and niche generic products. Anchen's mission is to utilize its aggressive Research and Development efforts along with manufacturing and marketing expertise to make available high quality generic products to patients in the US. Anchen takes pride in its creativity and speed in filling Abbreviated New Drug Applications (ANDAs) containing so called "Paragraph IV" certifications, which seek FDA approval to market generic drugs that avoid patents covering branded products. This creativity and speed is one of the key components to Anchen's corporate culture, current and future success.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Anchen Pharmaceuticals News

2022-03-22 - 2022 Worldwide Para IV Insights Database - Featuring 3M ...

Generic Pharma Investor ... Anacor Pharmaceuticals, Inc; Anchen; ANDA Inc; Andrx; Angelini pharma; ANI Pharma; annora pharma; Anthea pharma...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M408%$81.8M
#2
$4.6M40N/AN/A
#3
$8.2M4038%$23M
#4
$8.8M40-22%N/A
#5
$1.7M408%N/A